Open Longevity



A new project in the field of biotechnology, telemedicine, clinical research and medical services is completing preparations for pre-ICO. Open Longevity is being developed to organize research on aging therapies in humans through the provision of advisory services to users. The ultimate goal is to find and introduce effective methods of radical life extension into clinical practice. Therefore, our tokens are called YEAR. Creating a platform, we combine the capabilities of modern IT-systems, the expertise of leading scientific analysts and the concernment of the patients themselves—members of Open Longevity community and future users of our online platform. It is important to note another driving force of the project—its openness and rejection of commercial benefits in those matters where this can affect the objectivity of scientific research. We are sure that effective ways to delay the onset of old age will be found—it is only a matter of time. Open Longevity wants to accelerate scientific research by involving a large number of people in clinical trials of aging therapies and creating an online platform for people to monitor health status, receive necessary recommendations from gerontologists, nutritionists and physicians to form a personal strategy for improving and preserving health.

ICO Dates
Whitelist / KYC
Russian Federation
Token Type
Available for Sale
ICO price
1 YEAR = 0.1 USD
Soft Cap
7M $
Hard Cap
35M $
Mikhail Batin
Dmitry Veremeenko
Science advisor
  • 1
    Starting Q1 2018

    Platform: The server part of the platform, API, allocation; Implementing YEAR; Patient card; Collection of markers, analyzes and images; Diagnostic panels; Data statistics;

  • 2
    Starting Q2 2018

    Platform: Integration with laboratories (data acquisition without input); Development of iOS and Android applications; Integration with Gadgets; Customizable interface.

  • 3
    Starting Q3 2018

    Platform: Loading external databases. Marketplace: Creating an API. CI: Creation of a platform for conducting CI. Consultations: Video consulting.

  • 4
    Starting Q4 2018

    Platfrom: Integration with medical cards. Consultations: Rating system for doctors. CI: Voting system YEAR; Matching, selection of participants for CI; Launch the second study.

  • 5
    Starting Q1 2019

    Platform: Development of an external API platform. Diagnostics: Creating a neural network.

  • 6
    Starting Q2 2019

    Platform: Implementing ZeroX. Diagnostics: Neaural network + PubMed; Predictors of geroprotectors; Neuronet + DNA; Neural network + Images.

  • 7
    Starting Q4 2019

    Platform: Social network. CI: Launch of third study.